This trade is a follow-up to the MRNA position opened on Mar 17, 2026. With expiration arriving Apr 2nd and the stock trading below the strike at $49, it was time to make a decision — close early or let it ride.
Trade Update
MRNA – Closing Position
- 04/02/26 – Buy to Close MRNA $49 Put (04/02) @ $32
- Closed the position ahead of expiration to avoid assignment and free up capital.
Why I Closed It
With MRNA trading near or below the $49 strike at expiration, letting this one expire unmanaged wasn’t worth the risk. Rather than take assignment on a volatile biotech stock, I chose to buy back the put at $32, a disciplined exit that keeps capital available for the next opportunity.
The original premium collected was $105. Buying it back at $32 locks in a net gain of $73 per share — roughly 69% of max profit.